Telomir Pharmaceuticals, Inc. - Common Stock (NQ:TELO)
2.280
+1.070
(+88.43%)
Official Closing Price
Updated: 4:15 PM EDT, Jul 18, 2025
Add to My Watchlist
Price and Volume
Detailed QuoteVolume | 137,210,317 |
Open | 3.060 |
Bid (Size) | 2.150 (221) |
Ask (Size) | 2.160 (8) |
Prev. Close | 1.210 |
Today's Range | 2.040 - 3.100 |
52wk Range | 1.120 - 8.400 |
Shares Outstanding | 29,762,671 |
Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read More
Dow Falls Over 200 Points; 3M Earnings Top Views
July 18, 2025
Friday's session: top gainers and losers
July 18, 2025
Gapping stocks in Friday's session
July 18, 2025
These stocks are moving in today's pre-market session
June 05, 2025
Frequently Asked Questions
Is Telomir Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Telomir Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Telomir Pharmaceuticals, Inc. - Common Stock trade on?
Telomir Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Telomir Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Telomir Pharmaceuticals, Inc. - Common Stock is TELO on the Nasdaq Stock Market
What is the current price of Telomir Pharmaceuticals, Inc. - Common Stock?
The current price of Telomir Pharmaceuticals, Inc. - Common Stock is 2.280
When was Telomir Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Telomir Pharmaceuticals, Inc. - Common Stock was at 07/18/25 04:15 PM ET
What is the market capitalization of Telomir Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Telomir Pharmaceuticals, Inc. - Common Stock is 67.86M
How many shares of Telomir Pharmaceuticals, Inc. - Common Stock are outstanding?
Telomir Pharmaceuticals, Inc. - Common Stock has 68M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.